Market News How it works Learn FAQ
| RCT 0.0827 8.67% | NU 12.59 -16.95% | EWZ 34.15 -19.82% | BBD 2.93 -28.01% | TGL 0.2427 9.57% | AZTR 1.53 113.99% | ITUB 7.7 -20.37% | XP 15.705 -48.36% | NVD 3.99 -4.77% | SRTM 0.3 -30.28% | WFF 0.0898 12.25% | SPCX 146.9 -0.40% | PBR 22.5 -13.99% | SHFS 0.094 -29.00% | SOXL 90.5 8.31% | INTC 90.47 4.04% | VALE 12 -3.23% | NVDA 216 2.39% | CLRO 4.97 52.92% | NOK 8.64 6.14% | JBLU 2.37 -9.71% | TSLL 10.76 10.25% | CRWV 55.19 1.76% | GCDT 0.1545 -12.27% | SOXS 47.98 -8.54% | RIG 6.53 1.87% | NWGL 0.0869 5.98% | ABEV 2.83 -14.24% | RWM 14.5 -0.34% | BITO 10.65 -1.66% | AAL 12.2 0.74% | GPUS 0.1785 5.68% | TSLG 5.38 10.47% | T 20.85 -0.38% | SGRY 23.25 47.62% | IREN 25.43 2.11% | INTR 4.68 -34.91% | SBS 4.73 -26.09% | NFLX 63.9 -2.96% | GRAB 2.71 -2.87% | TSLA 391.62 5.21% | QID 14.22 -2.27% | WULF 11.98 5.83% | TQQQ 68.43 3.23% | CIFR 7.71 -2.90% | RBNE 0.17 -10.53% | SID 0.9118 -22.73% | SPDN 8.5 -0.47% | VZ 43.1 -3.49% | LUCD 0.5007 21.82%
BNBionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO)

NASDAQ Capital Market · Currency in USD
$1.16 ▲ +0.03 (+2.65%)
At close: Oct 26, 4:00 PM ET. Market closed.
$1.17 ▲ +0.01 (+0.86%)
After hours: Oct 26, 7:45 PM ET

Summary

Previous Close
$1.13
Open
$1.15
Day's Range
$1.14 – $1.16
52 Week Range
$1.00 – $2.23
Volume
62,368
Avg. Volume
708,642
Market Cap
$13.66M
Beta (5Y Monthly)
1.66
PE Ratio (TTM)
--
EPS (TTM)
-$2.79
Earnings Date
Nov 12, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$46.50

Profile: Bionano Genomics, Inc.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Full-time employees
96
CEO
Albert A. Luderer

Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analysis of structural variations in the genome using optical genome mapping. This technology is vital for deciphering genetic variations and their functional roles.

Earnings

Next report: Thu, Nov 12, 2026
EPS estimate -$0.45 · Revenue est. $8.44M
DateEst.Actual
Aug 10, 2026-$0.67-$0.64Beat
May 13, 2026-$0.81-$0.76Beat
Mar 23, 2026-$0.81-$0.03Beat
Nov 13, 2025-$1.81-$1.59Beat
Aug 14, 2025-$2.69-$1.99Beat
May 14, 2025-$3.49-$1.15Beat

Analyst view

Consensus price target
$46.50 ▲ +3,908.6%
Range $1.00 – $175.00
Rating: Buy
Buy 57% · Hold 43% · Sell 0%

Get free alerts on BNGO and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.